Ichimura K - Search Results

1

Human glioblastomas with no alterations of the CDKN2A (p16INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene.

Ichimura K, Schmidt EE, Goike HM, Collins VP. Ichimura K, et al. Oncogene. 1996 Sep 5;13(5):1065-72. Oncogene. 1996. PMID: 8806696

2

Amplification at 12q13-14 in human malignant gliomas is frequently accompanied by loss of heterozygosity at loci proximal and distal to the amplification site.

Reifenberger G, Reifenberger J, Ichimura K, Collins VP. Reifenberger G, et al. Among authors: ichimura k. Cancer Res. 1995 Feb 15;55(4):731-4. Cancer Res. 1995. PMID: 7850781

3

CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas.

Schmidt EE, Ichimura K, Reifenberger G, Collins VP. Schmidt EE, et al. Among authors: ichimura k. Cancer Res. 1994 Dec 15;54(24):6321-4. Cancer Res. 1994. PMID: 7987821

4

Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2.

Reifenberger G, Reifenberger J, Ichimura K, Meltzer PS, Collins VP. Reifenberger G, et al. Among authors: ichimura k. Cancer Res. 1994 Aug 15;54(16):4299-303. Cancer Res. 1994. PMID: 8044775

5

A common region of homozygous deletion in malignant human gliomas lies between the IFN alpha/omega gene cluster and the D9S171 locus.

Ichimura K, Schmidt EE, Yamaguchi N, James CD, Collins VP. Ichimura K, et al. Cancer Res. 1994 Jun 15;54(12):3127-30. Cancer Res. 1994. PMID: 8205529

6

[Molecular biological analysis of neurofibromatosis type 2 gene].

Ichimura K, Yuasa Y. Ichimura K, et al. Nihon Rinsho. 1993 Sep;51(9):2462-6. Nihon Rinsho. 1993. PMID: 8411729 Review. Japanese.

7

Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations.

Reifenberger G, Liu L, Ichimura K, Schmidt EE, Collins VP. Reifenberger G, et al. Among authors: ichimura k. Cancer Res. 1993 Jun 15;53(12):2736-9. Cancer Res. 1993. PMID: 8504413

8

Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets.

Reifenberger G, Ichimura K, Reifenberger J, Elkahloun AG, Meltzer PS, Collins VP. Reifenberger G, et al. Among authors: ichimura k. Cancer Res. 1996 Nov 15;56(22):5141-5. Cancer Res. 1996. PMID: 8912848

9

Infrequent methylation of CDKN2A(MTS1/p16) and rare mutation of both CDKN2A and CDKN2B(MTS2/p15) in primary astrocytic tumours.

Schmidt EE, Ichimura K, Messerle KR, Goike HM, Collins VP. Schmidt EE, et al. Among authors: ichimura k. Br J Cancer. 1997;75(1):2-8. doi: 10.1038/bjc.1997.2. Br J Cancer. 1997. PMID: 9000591 Free PMC article.

10

Frequent inactivation of CDKN2A and rare mutation of TP53 in PCNSL.

Cobbers JM, Wolter M, Reifenberger J, Ring GU, Jessen F, An HX, Niederacher D, Schmidt EE, Ichimura K, Floeth F, Kirsch L, Borchard F, Louis DN, Collins VP, Reifenberger G. Cobbers JM, et al. Among authors: ichimura k. Brain Pathol. 1998 Apr;8(2):263-76. doi: 10.1111/j.1750-3639.1998.tb00152.x. Brain Pathol. 1998. PMID: 9546285

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results